Posts Tagged ‘2010’
Pulmo BioTech Inc. Announces Attendance at RSNA 2010
NEW YORK — Pulmo BioTech Inc. announces that later this year it intends to exhibit at RSNA 2010, the 96th Scientific Assembly & Annual Meeting of the Radiological Society of North America, which hosts nearly 60,000 attendees from around the world.
Read more on GlobeNewswire via Yahoo! Finance
Relevant Resources
- Call for Proposals ABA Dispute Resolution Section Annual Meeting
- Lower Nemahbin Lake Association, Ltd. Annual Meeting, Monday, August 9, 2010, Summit Village Hall, 7 – 9 pm « Lower Nemahbin Lake Association
- FIFA: World Cup attendance third highest ever
- WORLD CUP ATTENDANCE TO PASS 3 MILLION TODAY | Soccer Jones | Football and Soccer News, Gossip and Analysis
- Major League Soccer Week 15 Attendance Stats & Review | The 90th Minute Soccer Blog
Clinical Trials Update: June 23, 2010
(HealthDay News) — Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Read more on HealthDay via Yahoo! News
Relevant Resources
- New Diabetes Drug Performs Well In Clinical Trial : dBTechno
- Clinical trial conflict of interest for doctors | KevinMD.com
- The effect of protocol amendments on statistical inference of clinical trials « Random John
- Dulera Inhaler Approved for Asthma (HealthDay) | eyescoops.ca
- Vitamins May Not Curb High Blood Pressure in Pregnant Diabetics (HealthDay) – HEALTHLIFESOURCE.COM on Natural Health Care News Information
Quark Pharmaceuticals Announces Presentations of its Two siRNA Drug Candidates at Glaucoma & Retinopathies 2010
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that two of its siRNA drug candidates were featured in the following two presentations at the Glaucoma & Retinopathies 2010 conference, which was held June 21-22, 2010 in London, UK:
Read more on PR Newswire via Yahoo! Finance
Relevant Resources
- The Company’s pipeline of internallydeveloped biologic drug candidates under evaluation includes Prochymal forinflammatory autoimmune « Beogradoglasi.com
- New method to synthesize drug candidates for testing – Bio
- Drug Law Reform as Political Litmus Test : Drop the Rock
- Access Pharmaceuticals, Inc. Presents MuGard Clinical Experience at MASCC Conference | Access Pharmaceuticals, Inc. Newsroom
- Molecular Insight Pharmaceuticals Inc. (MIPI) Company Brief | Beacon Equity Research
NicOx reports first quarter 2010 financial results
SOPHIA ANTIPOLIS, FRANCE–(Marketwire – May 7, 2010) – www.nicox.com — NicOx S.A. (NYSE Euronext Paris: COX) today reported financial results for the first three months of 2010 and provided an overview of its activities, in particular those related to its lead compound naproxcinod which is currently under review by the US Food and Drug Administration (FDA) and the …
Read more on Marketwire
MicroCHIPS receives 2010 Edison Best New Product Award for Illume System
MicroCHIPS, Inc., a developer of intelligent implant systems, today announced that it has received a 2010 Edison Best New Product Award for its Illume product. The product was awarded Gold in the Science and Medical Category, recognizing the benefit that it will bring to millions of people with diabetes who must manage their blood sugar intensively to stay healthy.
Read more on News-Medical-Net
Relevant Resources
- Israel Trade Commission :: Adin Dental Implant Systems Ltd.
- Fashion Verbatim » Blog Archive » Glucose and Blood Sugar Level Monitoring Made Easy
- How To Lower Blood Sugar Levels With Nutritional Supplements
- Because of my blood sugar I mistakely called the guest caller a islam – Apr 30,2010 – USWGO Alternative News
- Clinic hot topic – blood sugar and pancreas | The Health Detectives
